# Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs

> **NCT01365429** · NA · UNKNOWN · sponsor: **XVIVO Perfusion** · enrollment: 252 (actual)

## Conditions studied

- Lung Transplant

## Interventions

- **DEVICE:** XPS™ with Steen Solution™

## Key facts

- **NCT ID:** NCT01365429
- **Lead sponsor:** XVIVO Perfusion
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2017-12
- **Final completion:** 2020-12
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365429, "Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01365429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*